 comparison enalapril hydralazine-isosorbide dinitrate treatment chronic congestive heart failure BACKGROUND efficacy vasodilator therapy treatment chronic congestive heart failure effects hydralazine isosorbide dinitrate enalapril men digoxin diuretic therapy heart failure patients double-blind manner mg enalapril daily mg hydralazine mg isosorbide dinitrate daily latter regimen identical similar patient population effective-treatment arm previous Vasodilator-Heart Failure Trial RESULTS Mortality years enalapril arm percent hydralazine-isosorbide dinitrate arm percent reduction mortality percent overall mortality mortality enalapril arm attributable reduction incidence sudden death beneficial effect prominent patients severe symptoms New York Heart Association class II contrast body oxygen consumption peak exercise hydralazine-isosorbide dinitrate treatment ventricular ejection fraction regimens years randomization first weeks hydralazine-isosorbide dinitrate group CONCLUSIONS similar two-year mortality hydralazine-isosorbide dinitrate arms previous Vasodilator-Heart Failure Trial percent present trial percent placebo arm previous trial percent survival benefit enalapril present trial percent conclusion vasodilator therapy standard treatment heart failure different effects regimens enalapril hydralazine-isosorbide dinitrate mortality physiologic end points profile effects regimens combination